NMRA icon

Neumora Therapeutics

Buy
Hold
Sell

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$8
296% upside
High target

5 analyst ratings

positive
neutral
20%
negative
Analyst & Firm Rating Price Target Upside
Downside
Date
Leerink Partners
Leerink Partners
Marc Goodman
0% 1-yr NMRA win rate
12 Jan ‘26 6 days ago
RBC Capital
RBC Capital
Brian Abrahams
0% 1-yr NMRA win rate
1 Dec ‘25 1 month ago
Stifel
Stifel
Paul Matteis
17 Nov ‘25 2 months ago
Needham
Needham
Ami Fadia
25% 1-yr NMRA win rate
28 Oct ‘25 2 months ago
Guggenheim
Guggenheim
Yatin Suneja
0% 1-yr NMRA win rate
27 Oct ‘25 2 months ago